Literature DB >> 16203929

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

Sandeep R Das1, Mark H Drazner, Daniel L Dries, Gloria L Vega, Harold G Stanek, Shuaib M Abdullah, Russell M Canham, Anne K Chung, David Leonard, Frank H Wians, James A de Lemos.   

Abstract

BACKGROUND: The association between higher body mass index (BMI) and lower B-type natriuretic peptide (BNP) level is thought to be mediated by expression of the natriuretic peptide clearance receptor (NPR-C) in adipose tissue. To explore this association, we tested 2 hypotheses: (1) that N-terminal (NT)-proBNP, which is not believed to bind NPR-C, would not be associated with BMI and (2) that lower BNP would be more closely associated with fat mass than with lean mass. METHODS AND
RESULTS: Measurements of BNP, NT-proBNP, and body composition by direct dual energy x-ray absorptiometry (DEXA) were performed in 2707 subjects from the Dallas Heart Study. The associations between obesity and low BNP (<4 ng/L) or low NT-proBNP (lowest sex-specific quartile) were evaluated with multivariable logistic regression models stratified by sex and adjusted for age, race/ethnicity, hypertension, left ventricular mass, and end-diastolic volume. Higher BMI was independently associated with lower BNP and NT-proBNP (all P<0.001). When BMI was replaced with both DEXA-derived lean and fat mass, greater lean mass, but not fat mass, was associated with low BNP and NT-proBNP levels.
CONCLUSIONS: In a large, population-based cohort, we confirm the previously described association between higher BMI and lower BNP and demonstrate a similar inverse association between BMI and NT-proBNP. Interestingly, both BNP and NT-proBNP are more closely associated with lean mass than with fat mass. These findings do not support the hypothesis that the lower BNP levels seen in obesity are driven by enhanced BNP clearance mediated via NPR-C.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203929     DOI: 10.1161/CIRCULATIONAHA.105.555573

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  126 in total

1.  Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.

Authors:  Jeong Rang Park; Jin-Oh Choi; Hye Jin Han; Sung-A Chang; Sung-Ji Park; Sang-Chol Lee; Yeon Hyeon Choe; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-24       Impact factor: 2.357

2.  Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.

Authors:  Alain G Bertoni; Lynne E Wagenknecht; Dalane W Kitzman; Santica M Marcovina; Julia T Rushing; Mark A Espeland
Journal:  Obesity (Silver Spring)       Date:  2011-09-29       Impact factor: 5.002

Review 3.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

4.  Identifying biomarker patterns and predictors of inflammation and myocardial stress.

Authors:  Ruth M Masterson Creber; Christopher S Lee; Kenneth Margulies; Barbara Riegel
Journal:  J Card Fail       Date:  2015-02-26       Impact factor: 5.712

5.  Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.

Authors:  J G Berry; B Askovich; R E Shaddy; J A Hawkins; C G Cowley
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

Review 6.  Natriuretic peptides in the diagnosis and management of heart failure.

Authors:  G Michael Felker; John W Petersen; Daniel B Mark
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

7.  Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.

Authors:  Navin Suthahar; Wouter C Meijers; Jennifer E Ho; Ron T Gansevoort; Adriaan A Voors; Peter van der Meer; Stephan J L Bakker; Stephane Heymans; Vanessa van Empel; Blanche Schroen; Pim van der Harst; Dirk J van Veldhuisen; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2018-06-01       Impact factor: 15.534

8.  Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.

Authors:  Susan Cheng; Caroline S Fox; Martin G Larson; Joseph M Massaro; Elizabeth L McCabe; Abigail May Khan; Daniel Levy; Udo Hoffmann; Christopher J O'Donnell; Karen K Miller; Christopher Newton-Cheh; Andrea D Coviello; Shalender Bhasin; Ramachandran S Vasan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2011-08-01       Impact factor: 2.778

9.  Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.

Authors:  Geoffrey A Walford; Yong Ma; Costas A Christophi; Ronald B Goldberg; Petr Jarolim; Edward Horton; Kieren J Mather; Elizabeth Barrett-Connor; Jaclyn Davis; Jose C Florez; Thomas J Wang
Journal:  Diabetologia       Date:  2014-02-20       Impact factor: 10.122

10.  Gastric bypass surgery elevates NT-ProBNP levels.

Authors:  Niclas Abrahamsson; Britt Edén Engström; Magnus Sundbom; F Anders Karlsson
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.